台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    93.6
  • 漲跌
    ▲3.3
  • 漲幅
    +3.65%
  • 成交量
    862
  • 產業
    上櫃 生技醫療類股▼0.59%
  • 305人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-富邦-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-南京 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/0200.00294.4093.60-21,235-0.16%
2024/12/26192.5000.0092.5011,2250.08%
2024/12/13388.0000.0088.8031,2090.25%
2024/12/11291.4000.0090.6021,1930.17%
2024/12/0900.000.193.5092.50-0.11,184-0.01%
2024/12/04294.70195.3094.6011,1640.09%
2024/12/030.195.1000.0094.400.11,1610.01%
2024/11/28591.5000.0092.4051,1100.45%
2024/11/260.394.20594.0094.00-4.71,084-0.43%
2024/11/21196.60197.4096.2001,0210.00%
2024/11/19196.20196.5096.0001,0150.00%
2024/11/1500.002101.9999.90-2989-0.20%
2024/11/143104.331106.50101.5029710.21%
2024/11/1300.0030.1106.00106.50-30.1946-3.17%
2024/11/1100.001105.00103.50-1882-0.11%
2024/11/082102.500.1104.00103.0028730.22%
2024/11/0613106.008104.38102.5058260.60%
2024/11/054106.885.1106.40106.00-1.1782-0.13%
2024/11/041101.5000.00100.0017580.13%
2024/11/0140104.1311.4107.28105.0028.67303.92%
2024/10/291100.503101.00100.50-2604-0.33%
2024/10/2800.001103.00102.00-1576-0.17%
2024/10/24297.253.299.3298.30-1.2494-0.24%
2024/10/230.294.60188.1093.70-0.8424-0.19%
2024/10/22186.7000.0086.7014040.25%
2024/10/21187.2000.0086.7014180.24%
2024/10/0900.000.191.3089.50-0.1508-0.02%
2024/10/0800.002092.9591.10-20507-3.94%
2024/09/30190.30190.0089.5005500.00%
2024/09/24387.7000.0090.2036120.49%
2024/09/1900.00183.4086.00-1636-0.16%
2024/09/18283.5000.0082.9026330.32%
2024/09/1000.00583.2283.30-5662-0.75%
2024/09/0900.00282.0082.00-2666-0.30%
2024/09/03486.2000.0085.7047130.56%
2024/08/30186.90187.6087.6007260.00%
2024/08/2700.00286.9586.50-2734-0.27%
2024/08/2600.00287.1586.70-2738-0.27%
2024/08/22287.00487.6086.60-2740-0.27%
2024/08/21286.30287.0086.6007460.00%
2024/08/20286.500.186.4285.801.97420.26%
2024/08/160.184.600.284.6084.60-0.1743-0.02%
2024/08/15183.80184.4084.5007450.00%
2024/08/14184.00284.1083.60-1755-0.13%
2024/08/1200.00283.9084.90-2780-0.26%
2024/08/09385.90287.3085.4017830.13%
2024/08/06279.7000.0080.8027830.26%
2024/08/05883.00183.3083.0077640.92%
2024/07/30193.8000.0093.6017360.14%
2024/07/2900.00495.7394.50-4736-0.54%
2024/07/2600.00796.4097.60-7729-0.96%
2024/07/1800.00699.3899.40-6676-0.89%
2024/07/16197.0000.0097.0016580.15%
2024/07/151098.26498.7898.4066630.90%
2024/07/12297.00195.9095.6016480.15%
2024/07/11395.60495.8095.20-1650-0.15%
2024/07/10297.7000.0096.6026580.30%
2024/07/09197.6000.0096.3016680.15%
2024/07/0800.006.2100.11100.50-6.2655-0.95%
2024/07/0500.00197.5097.50-1625-0.16%
2024/07/040.196.1000.0096.000.16260.02%
2024/07/031.797.0500.0096.701.76280.27%
2024/07/02798.79399.7797.8046230.64%
2024/07/0100.00499.90101.00-4610-0.65%
2024/06/2700.00198.2095.70-1582-0.17%
2024/06/2600.00797.6697.60-7576-1.21%
2024/06/24193.9000.0093.2015890.17%
2024/06/21093.6000.0093.7006070.00%
2024/06/20294.5000.0094.5026350.31%
2024/06/190.194.64394.1093.80-2.9637-0.46%
2024/06/18095.1000.0095.4006330.00%
2024/06/174.195.8500.0095.504.16440.63%
2024/06/140.196.0000.0095.300.16550.01%
2024/06/1300.00996.8496.90-9651-1.38%
2024/06/07693.581.192.6394.504.96440.76%
2024/06/06391.70591.8091.10-2630-0.32%
2024/06/05292.85292.0092.9006320.00%
2024/06/04291.40691.9790.80-4647-0.62%
2024/06/03390.8300.0090.7036930.43%
2024/05/31291.30791.3390.60-5729-0.69%
2024/05/30191.5000.0090.3017370.14%
2024/05/29192.0000.0091.5017470.13%
2024/05/27191.60491.6091.70-3776-0.39%
2024/05/23194.0000.0093.6018420.12%
2024/05/2200.001494.5494.10-14847-1.65%
2024/05/2000.000.297.0096.90-0.2865-0.02%
2024/05/17198.50198.0097.9008720.00%
2024/05/1600.00295.3095.10-2869-0.23%
2024/05/1500.00294.9093.90-2952-0.21%
2024/05/14295.35296.4594.3001,0430.00%
2024/05/09193.6000.0093.3011,0720.09%
2024/05/08393.7000.0094.0031,0960.27%
2024/05/0700.00693.4092.80-61,116-0.54%
2024/04/2500.00491.0390.60-41,449-0.28%
2024/04/22589.24190.0088.0041,5120.26%
2024/04/1800.00592.6893.60-51,525-0.33%
2024/04/17192.5000.0092.6011,5410.06%
2024/04/1500.00296.0094.10-21,565-0.13%
2024/04/082.199.5000.0099.102.11,7700.12%
2024/04/0300.00197.5099.00-11,777-0.06%
2024/04/020.199.4400.0098.900.11,7800.01%
2024/03/29198.5000.0099.2011,8130.06%
2024/03/280.299.603100.0099.40-2.81,839-0.15%
2024/03/2700.00199.5099.70-11,828-0.05%
2024/03/261.397.70297.6096.80-0.71,818-0.04%
2024/03/251.198.7300.00101.001.11,8160.06%
2024/03/2200.00296.1096.50-21,801-0.11%
2024/03/2100.00396.0096.00-31,827-0.16%
2024/03/206.195.9000.0095.806.11,8550.33%
2024/03/19297.75196.9096.8011,8640.05%
2024/03/18293.9000.0093.3021,8550.11%
2024/03/1400.00993.0092.70-91,882-0.48%
2024/03/13194.20492.6592.40-31,896-0.16%
2024/03/12195.8000.0095.6011,8890.05%
2024/03/08195.80596.0095.10-41,924-0.21%
2024/03/07295.352.398.6199.30-0.31,930-0.02%
2024/03/06598.30599.0098.1001,9370.00%
2024/03/050.3101.0000.00100.500.31,9140.02%
2024/03/013102.503103.50101.5001,9390.00%
2024/02/274103.631104.50103.0031,9950.15%
2024/02/2600.001104.00104.50-11,990-0.05%
2024/02/231101.0000.00101.0011,9810.05%
2024/02/210103.0000.00101.5002,0430.00%
2024/02/203101.3300.00101.5032,0580.15%
2024/02/1910102.0011102.18101.50-12,075-0.05%
2024/02/1610102.4516102.72102.00-62,096-0.29%
2024/02/154111.502112.00110.5022,0600.10%
2024/01/312106.5000.00106.0022,3960.08%
2024/01/307104.935105.00105.0022,7020.07%
2024/01/292107.501106.00106.0012,7600.04%
2024/01/2619110.9532110.19108.50-132,838-0.46%
2024/01/255105.405104.00105.0002,7820.00%
2024/01/242101.0000.00100.5022,8960.07%
2024/01/181098.361099.5098.5003,8140.00%
2024/01/171199.817101.8498.3044,0790.10%
2024/01/164102.006103.25102.50-24,486-0.04%
2024/01/154105.252104.00104.5024,5860.04%
2024/01/1200.002102.75103.00-24,603-0.04%
2024/01/116102.0038102.18101.50-324,609-0.69%
2024/01/106102.3337102.27102.00-314,615-0.67%
2024/01/092104.503107.17104.50-14,602-0.02%
2024/01/088107.696107.83108.0024,5920.04%
2024/01/053106.005108.20109.00-24,607-0.04%
2024/01/0415104.805106.00103.00104,5930.22%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章